Ratios Uncovered: Breaking Down Liquidia Corp (LQDA)’s Trailing Twelve Months Metrics

The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The price of Liquidia Corp (NASDAQ: LQDA) closed at $11.09 in the last session, down -0.45% from day before closing price of $11.14. In other words, the price has decreased by -$0.45 from its previous closing price. On the day, 1.0 million shares were traded. LQDA stock price reached its highest trading level at $11.2039 during the session, while it also had its lowest trading level at $10.87.

Ratios:

We take a closer look at LQDA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 5.78 and its Current Ratio is at 6.08. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.03.

On August 16, 2024, Raymond James started tracking the stock assigning a Outperform rating and target price of $27.Raymond James initiated its Outperform rating on August 16, 2024, with a $27 target price.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Oct 14 ’24 when Schundler Russell sold 2,576 shares for $11.11 per share. The transaction valued at 28,613 led to the insider holds 486,048 shares of the business.

Saggar Rajeev sold 2,260 shares of LQDA for $25,103 on Oct 14 ’24. The Chief Medical Officer now owns 207,383 shares after completing the transaction at $11.11 per share. On Oct 14 ’24, another insider, Moomaw Scott, who serves as the Chief Commercial Officer of the company, sold 1,527 shares for $11.11 each. As a result, the insider received 16,961 and left with 152,798 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LQDA now has a Market Capitalization of 935752064 and an Enterprise Value of 811257728. For the stock, the TTM Price-to-Sale (P/S) ratio is 62.21 while its Price-to-Book (P/B) ratio in mrq is 13.51. Its current Enterprise Value per Revenue stands at 54.667 whereas that against EBITDA is -8.465.

Stock Price History:

Over the past 52 weeks, LQDA has reached a high of $16.99, while it has fallen to a 52-week low of $5.71. The 50-Day Moving Average of the stock is 6.19%, while the 200-Day Moving Average is calculated to be -11.70%.

Shares Statistics:

According to the various share statistics, LQDA traded on average about 1.25M shares per day over the past 3-months and 864130 shares per day over the past 10 days. A total of 68.63M shares are outstanding, with a floating share count of 58.20M. Insiders hold about 30.09% of the company’s shares, while institutions hold 45.28% stake in the company. Shares short for LQDA as of 1727654400 were 11839099 with a Short Ratio of 9.50, compared to 1724976000 on 12255298. Therefore, it implies a Short% of Shares Outstanding of 11839099 and a Short% of Float of 21.63.

Most Popular